SCHEMBL1979674

SCHEMBL1979674

CC(C)(C)c1cnc(N)o1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 9/20 0.45
KDM4E B2RXH2 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
CCNE2 O96020 6/20 0.33
CDK1 P06493 6/20 0.33
CCNB1 P14635 6/20 0.33
CCNE1 P24864 6/20 0.33
CCNB2 O95067 5/20 0.33
CDK4 P11802 5/20 0.33
CCND1 P24385 5/20 0.33
CCNB3 Q8WWL7 5/20 0.33
CCND2 P30279 3/20 0.33
CCND3 P30281 3/20 0.33
PIK3CG P48736 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.31
CCNT1 O60563 1/20 0.31
CDK7 P50613 1/20 0.31
CDK9 P50750 1/20 0.31
CCNH P51946 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23609798 0.75 CDK2 (0.59) CDK2CCNE2CDK1CCNB1CCNE1
SCHEMBL2616422 0.72 CDK2 (0.35) CDK2PIK3CGL3MBTL1
SCHEMBL2619433 0.72 PIK3CG (0.41) CDK2PIK3CG
SCHEMBL10268216 0.71 CDK2 (0.46) CDK2CCNE2CDK1CCNB1CCNE1
Hydrochloric Acid SCHEMBL3710324 0.70 CDK2 (0.45) CDK2CCNE2CDK1CCNB1CCNE1
SCHEMBL14112956 0.70 CDK2 (0.34) CDK2
SCHEMBL21720208 0.70 CDK2 (0.34) CDK2RAB9AL3MBTL1
SCHEMBL21720481 0.70 CDK2 (0.34) CDK2
SCHEMBL17801609 0.70 CDK2 (0.34) CDK2
SCHEMBL18647269 0.70 CDK2 (0.34) CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023237759-A1 DIHYDRO[1,8]NAPHTHYRIDIN-7-ONE AND PYRIDO[3,2-B][1,4]OXAZIN-3-ONE FOR USE IN TREATING CANCER, AND METASTASES IN PARTICULAR ANAGENESIS BIOTECHNOLOGIES (FR) 2023-12-14 WO disclosed
EP-4289427-A1 DIHYDRO[1,8]NAPHTHYRIDIN-7-ONE AND PYRIDO[3,2-B][1,4]OXAZIN-3-ONE FOR USE IN TREATING CANCER, AND METASTASES IN PARTICULAR. Anagenesis Biotechnologies (FR) 2023-12-13 EP disclosed
EP-4289427-A1 DIHYDRO[1,8]NAPHTHYRIDIN-7-ONE AND PYRIDO[3,2-B][1,4]OXAZIN-3-ONE FOR USE IN TREATING CANCER, AND METASTASES IN PARTICULAR. Anagenesis Biotechnologies (FR) 2023-12-13 EP disclosed
US-11178870-B2 Pyridone compounds and agricultural and horticultural fungicides containing the same as active ingredients MITSUI CHEMICALS AGRO, INC. (JP) 2021-11-23 US disclosed
US-10947237-B2 Antimicrobial compounds and methods of making and using the same BioVersys AG (CH) 2021-03-16 US disclosed
US-20200045968-A1 PYRIDONE COMPOUNDS AND AGRICULTURAL AND HORTICULTURAL FUNGICIDES CONTAINING THE SAME AS ACTIVE INGREDIENTS MITSUI CHEMICALS AGRO, INC. (JP) 2020-02-13 US disclosed
US-20180065966-A1 Antimicrobial Compounds And Methods Of Making And Using The Same MELINTA THERAPEUTICS, INC. 2018-03-08 US disclosed
US-20180065966-A1 Antimicrobial Compounds And Methods Of Making And Using The Same MELINTA THERAPEUTICS, INC. 2018-03-08 US disclosed
US-9657057-B2 Dipeptide and tripeptide epoxy ketone protease inhibitors ONYX THERAPEUTICS, INC. (US) 2017-05-23 US disclosed
US-9657057-B2 Dipeptide and tripeptide epoxy ketone protease inhibitors ONYX THERAPEUTICS, INC. (US) 2017-05-23 US disclosed
EP-2509980-A1 HETEROCYCLIC COMPOUNDS CONTAINING AN INDOLE CORE Boehringer Ingelheim International GmbH (DE) 2012-10-17 EP disclosed
US-8101611-B2 Substituted pyridazines inhibitors of MEK ARRAY BIOPHARMA INC. (US) 2012-01-24 US disclosed
WO-2011071716-A1 HETEROCYCLIC COMPOUNDS CONTAINING AN INDOLE CORE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-06-16 WO disclosed
WO-2011071716-A1 HETEROCYCLIC COMPOUNDS CONTAINING AN INDOLE CORE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-06-16 WO disclosed
US-20090258885-A1 Diphenylmethane Derivatives as Inhibitors of Leukotriene Biosynthesis MERCK SHARP & DOHME CORP. 2009-10-15 US disclosed
US-20090197883-A1 Diphenyl Substituted Cycloalkanes, Compositions Containing Such Compounds and Methods Of Use MERCK SHARP & DOHME CORP. 2009-08-06 US disclosed
US-20080293714-A1 Tec Kinase Inhibitors BENTZIEN JOERG MARTIN 2008-11-27 US disclosed
EP-0378791-A2 3,4-Dimethyl-pyrrolidine derivatives NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1990-07-25 EP disclosed
US-4909828-A Containing 1,3,4-oxadiazole ring structure NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1990-03-20 US disclosed
EP-0339390-A1 Herbicidal 2,5-dihydropyrroles NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1989-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090258885-A1 Diphenylmethane Derivatives as Inhibitors of Leukotriene Biosynthesis LTC4S, LTA4H, ALOX5 CDK2 1505/4885KDM4E 3207/4885NPC1 676/4885
US-11178870-B2 Pyridone compounds and agricultural and horticultural fungicides containing the same as active ingredients PNPO, CYP4X1, PDXK CDK2 580/4885KDM4E 595/4885NPC1 3861/4885
US-20200045968-A1 PYRIDONE COMPOUNDS AND AGRICULTURAL AND HORTICULTURAL FUNGICIDES CONTAINING THE SAME AS ACTIVE INGREDIENTS PNPO, CYP4X1, PDXK CDK2 580/4885KDM4E 595/4885NPC1 3861/4885
US-20180065966-A1 Antimicrobial Compounds And Methods Of Making And Using The Same LPO, MPO, CAT CDK2 4672/4885KDM4E 4341/4885NPC1 1174/4885
US-20080293714-A1 Tec Kinase Inhibitors TEC, ITK, TXK CDK2 172/4885KDM4E 2152/4885NPC1 4218/4885
US-10947237-B2 Antimicrobial compounds and methods of making and using the same LPO, MPO, CAT CDK2 4672/4885KDM4E 4341/4885NPC1 1174/4885
US-20090197883-A1 Diphenyl Substituted Cycloalkanes, Compositions Containing Such Compounds and Methods Of Use ALOX5, LTC4S, ALOX15B CDK2 2646/4885KDM4E 3254/4885NPC1 450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.